Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07733245 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of HRS-9190 in General Anesthesia

StatusEnrolling by Invitation
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrolling by invitation only
    • Start date changed from estimate of Jul 28, 2026 to Sep 2, 2026
    • Site contact updated
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A multicenter, randomized, double - blind, placebo - controlled, parallel - group phase III clinical trial was carried out to evaluate the efficacy and safety of HRS - 9190 for skeletal muscle relaxation during tracheal intubation in the induction and maintenance phases of general anesthesia. The primary objective was to evaluate the effectiveness of HRS - 9190 in achieving skeletal muscle relaxation during tracheal intubation in the induction and maintenance phases of general anesthesia. The secondary objective was to assess the safety and pharmacokinetic profile of HRS - 9190.
Trial Details
NCT Number NCT07733245
Lead Sponsor The Third Xiangya Hospital of Central South University
Collaborators: Jiangsu Hengrui Pharmaceutical Co., Ltd.
Conditions
(from sponsor)		 Adult Participants Requiring Tracheal Intubation Under General Anesthesia for Elective Surgery
Related terms Muscle Hypotonia
Enrollment 320 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov